SCHEMBL17500110

SCHEMBL17500110

O=Cc1ccn([C@H]2C[C@@H](NC(=O)O)C2)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ HTT P42858 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ OPRK1 P41145 2/20 0.32
▸ HTR3E A5X5Y0 1/20 0.32
▸ SLC22A2 O15244 1/20 0.32
▸ HTR3B O95264 1/20 0.32
▸ CHRNB2 P17787 1/20 0.32
▸ CHRNA3 P32297 1/20 0.32
▸ CHRNA4 P43681 1/20 0.32
▸ HTR3A P46098 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ HTR3D Q70Z44 1/20 0.32
▸ HTR3C Q8WXA8 1/20 0.32
▸ SLC47A1 Q96FL8 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17926705 1.00 ATM (0.33) ATMALDH1A1HTTLMNAKDM4E
SCHEMBL17500111 1.00 ATM (0.33) ATMALDH1A1HTTLMNAKDM4E
SCHEMBL21492118 0.76 MAPT (0.38) ATMALDH1A1HTTLMNAKDM4E
SCHEMBL17926664 0.75 ALDH1A1 (0.34) ATMALDH1A1KDM4EHTR3ESLC22A2
SCHEMBL17500098 0.75 ALDH1A1 (0.34) ATMALDH1A1KDM4EHTR3ESLC22A2
SCHEMBL17500096 0.75 ALDH1A1 (0.34) ATMALDH1A1KDM4EHTR3ESLC22A2
SCHEMBL25363826 0.74 ALDH1A1 (0.31) ALDH1A1LMNA
SCHEMBL23705805 0.73 — —
SCHEMBL17500115 0.71 SMYD3 (0.36) ATMALDH1A1HTTLMNAOPRK1
SCHEMBL17500118 0.71 SMYD3 (0.36) ATMALDH1A1HTTLMNAOPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016115090-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR INCREASING CFTR ACTIVITY PROTEOSTASIS THERAPEUTICS, INC. (US) 2016-07-21 — — WO disclosed
WO-2015196071-A9 COMPOUNDS, COMPOSITIONS AND METHODS OF INCREASING CFTR ACTIVITY PROTEOSTASIS THERAPEUTICS, INC. (US) 2016-02-18 — — WO disclosed
Send feedback